Genomic alteration profile and <scp>PD‐L1</scp> expression among different breast cancer subtypes in Chinese population and their correlations
Cited by 4
Related Papers
anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
|Cell Death and Disease|2020|185
Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
|Cell Communication and Signaling|2022|33
<p>Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation</p>
|OncoTargets and Therapy|2020|16